nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—NAT2—pineal body—malignant glioma	0.0746	0.296	CbGeAlD
Clonazepam—CYP3A4—Temozolomide—malignant glioma	0.0448	1	CbGbCtD
Clonazepam—Hemiparesis—Temozolomide—malignant glioma	0.0222	0.0399	CcSEcCtD
Clonazepam—Pigmentation disorder—Temozolomide—malignant glioma	0.014	0.0251	CcSEcCtD
Clonazepam—Niclosamide—STAT3—malignant glioma	0.013	0.488	CrCbGaD
Clonazepam—Paresis—Temozolomide—malignant glioma	0.0128	0.0229	CcSEcCtD
Clonazepam—Abnormal behaviour—Temozolomide—malignant glioma	0.0125	0.0225	CcSEcCtD
Clonazepam—TSPO—blood vessel—malignant glioma	0.0109	0.0431	CbGeAlD
Clonazepam—Disorder sight—Temozolomide—malignant glioma	0.00979	0.0176	CcSEcCtD
Clonazepam—Cerebration impaired—Temozolomide—malignant glioma	0.00793	0.0142	CcSEcCtD
Clonazepam—Haemorrhoids—Temozolomide—malignant glioma	0.00793	0.0142	CcSEcCtD
Clonazepam—Tooth disorder—Temozolomide—malignant glioma	0.00719	0.0129	CcSEcCtD
Clonazepam—GABRB2—brainstem—malignant glioma	0.00702	0.0279	CbGeAlD
Clonazepam—Apathy—Temozolomide—malignant glioma	0.00653	0.0117	CcSEcCtD
Clonazepam—TSPO—embryo—malignant glioma	0.00648	0.0257	CbGeAlD
Clonazepam—Flat affect—Temozolomide—malignant glioma	0.00647	0.0116	CcSEcCtD
Clonazepam—Scotoma—Carmustine—malignant glioma	0.00635	0.0114	CcSEcCtD
Clonazepam—Menorrhagia—Temozolomide—malignant glioma	0.0063	0.0113	CcSEcCtD
Clonazepam—GABRB2—telencephalon—malignant glioma	0.00623	0.0247	CbGeAlD
Clonazepam—GABRG2—telencephalon—malignant glioma	0.00623	0.0247	CbGeAlD
Clonazepam—GABRA1—brainstem—malignant glioma	0.0062	0.0246	CbGeAlD
Clonazepam—Scotoma—Temozolomide—malignant glioma	0.00614	0.011	CcSEcCtD
Clonazepam—Coagulopathy—Temozolomide—malignant glioma	0.00599	0.0107	CcSEcCtD
Clonazepam—Memory impairment—Temozolomide—malignant glioma	0.00594	0.0107	CcSEcCtD
Clonazepam—TSPO—brainstem—malignant glioma	0.00594	0.0236	CbGeAlD
Clonazepam—TSPO—retina—malignant glioma	0.00573	0.0228	CbGeAlD
Clonazepam—Endocrine disorder—Temozolomide—malignant glioma	0.00562	0.0101	CcSEcCtD
Clonazepam—GABRA1—telencephalon—malignant glioma	0.0055	0.0219	CbGeAlD
Clonazepam—Disturbance in attention—Temozolomide—malignant glioma	0.00538	0.00966	CcSEcCtD
Clonazepam—Breast pain—Temozolomide—malignant glioma	0.00534	0.00959	CcSEcCtD
Clonazepam—TSPO—telencephalon—malignant glioma	0.00527	0.0209	CbGeAlD
Clonazepam—Viral infection—Temozolomide—malignant glioma	0.00516	0.00926	CcSEcCtD
Clonazepam—Herpes simplex—Temozolomide—malignant glioma	0.00506	0.00908	CcSEcCtD
Clonazepam—Gait disturbance—Carmustine—malignant glioma	0.00494	0.00887	CcSEcCtD
Clonazepam—Clozapine—CALY—malignant glioma	0.00492	0.185	CrCbGaD
Clonazepam—Coordination abnormal—Carmustine—malignant glioma	0.00491	0.00882	CcSEcCtD
Clonazepam—GABRG2—medulla oblongata—malignant glioma	0.0049	0.0194	CbGeAlD
Clonazepam—GABRB2—medulla oblongata—malignant glioma	0.0049	0.0194	CbGeAlD
Clonazepam—Gait disturbance—Temozolomide—malignant glioma	0.00478	0.00857	CcSEcCtD
Clonazepam—Coordination abnormal—Temozolomide—malignant glioma	0.00475	0.00852	CcSEcCtD
Clonazepam—Vaginal inflammation—Temozolomide—malignant glioma	0.00466	0.00837	CcSEcCtD
Clonazepam—Depressed level of consciousness—Carmustine—malignant glioma	0.00466	0.00836	CcSEcCtD
Clonazepam—Urinary incontinence—Carmustine—malignant glioma	0.00466	0.00836	CcSEcCtD
Clonazepam—Candida infection—Carmustine—malignant glioma	0.00461	0.00827	CcSEcCtD
Clonazepam—Depressed level of consciousness—Temozolomide—malignant glioma	0.0045	0.00808	CcSEcCtD
Clonazepam—Urinary incontinence—Temozolomide—malignant glioma	0.0045	0.00808	CcSEcCtD
Clonazepam—GABRB2—midbrain—malignant glioma	0.00447	0.0178	CbGeAlD
Clonazepam—GABRG2—midbrain—malignant glioma	0.00447	0.0178	CbGeAlD
Clonazepam—Candida infection—Temozolomide—malignant glioma	0.00445	0.00799	CcSEcCtD
Clonazepam—Coma—Carmustine—malignant glioma	0.00441	0.00791	CcSEcCtD
Clonazepam—Vaginal infection—Temozolomide—malignant glioma	0.0044	0.0079	CcSEcCtD
Clonazepam—GABRB2—spinal cord—malignant glioma	0.00437	0.0173	CbGeAlD
Clonazepam—GABRG2—spinal cord—malignant glioma	0.00437	0.0173	CbGeAlD
Clonazepam—GABRA3—central nervous system—malignant glioma	0.00434	0.0173	CbGeAlD
Clonazepam—GABRA1—medulla oblongata—malignant glioma	0.00432	0.0172	CbGeAlD
Clonazepam—Gynaecomastia—Carmustine—malignant glioma	0.00432	0.00775	CcSEcCtD
Clonazepam—Mental disability—Carmustine—malignant glioma	0.00419	0.00751	CcSEcCtD
Clonazepam—TSPO—medulla oblongata—malignant glioma	0.00414	0.0164	CbGeAlD
Clonazepam—Mental disability—Temozolomide—malignant glioma	0.00405	0.00726	CcSEcCtD
Clonazepam—Thrombophlebitis—Carmustine—malignant glioma	0.00405	0.00726	CcSEcCtD
Clonazepam—Swelling—Carmustine—malignant glioma	0.00397	0.00712	CcSEcCtD
Clonazepam—Ear pain—Temozolomide—malignant glioma	0.00397	0.00712	CcSEcCtD
Clonazepam—GABRA1—midbrain—malignant glioma	0.00395	0.0157	CbGeAlD
Clonazepam—Thrombophlebitis—Temozolomide—malignant glioma	0.00391	0.00702	CcSEcCtD
Clonazepam—GABRA1—spinal cord—malignant glioma	0.00385	0.0153	CbGeAlD
Clonazepam—TSPO—midbrain—malignant glioma	0.00378	0.015	CbGeAlD
Clonazepam—Amnesia—Carmustine—malignant glioma	0.00373	0.00669	CcSEcCtD
Clonazepam—TSPO—spinal cord—malignant glioma	0.00369	0.0147	CbGeAlD
Clonazepam—Amnesia—Temozolomide—malignant glioma	0.0036	0.00647	CcSEcCtD
Clonazepam—Thirst—Temozolomide—malignant glioma	0.00356	0.00638	CcSEcCtD
Clonazepam—GABRG2—central nervous system—malignant glioma	0.00354	0.0141	CbGeAlD
Clonazepam—GABRB2—central nervous system—malignant glioma	0.00354	0.0141	CbGeAlD
Clonazepam—Diplopia—Carmustine—malignant glioma	0.0035	0.00629	CcSEcCtD
Clonazepam—GABRB2—cerebellum—malignant glioma	0.00346	0.0137	CbGeAlD
Clonazepam—GABRG2—cerebellum—malignant glioma	0.00346	0.0137	CbGeAlD
Clonazepam—GABRA3—brain—malignant glioma	0.00345	0.0137	CbGeAlD
Clonazepam—Diplopia—Temozolomide—malignant glioma	0.00338	0.00607	CcSEcCtD
Clonazepam—Face oedema—Carmustine—malignant glioma	0.00338	0.00607	CcSEcCtD
Clonazepam—Affect lability—Temozolomide—malignant glioma	0.00333	0.00598	CcSEcCtD
Clonazepam—Ataxia—Carmustine—malignant glioma	0.00329	0.00591	CcSEcCtD
Clonazepam—Face oedema—Temozolomide—malignant glioma	0.00327	0.00586	CcSEcCtD
Clonazepam—Liver function test abnormal—Carmustine—malignant glioma	0.00323	0.0058	CcSEcCtD
Clonazepam—Mood swings—Temozolomide—malignant glioma	0.00321	0.00575	CcSEcCtD
Clonazepam—Ataxia—Temozolomide—malignant glioma	0.00318	0.00571	CcSEcCtD
Clonazepam—Dehydration—Temozolomide—malignant glioma	0.00315	0.00565	CcSEcCtD
Clonazepam—GABRA1—central nervous system—malignant glioma	0.00313	0.0124	CbGeAlD
Clonazepam—Muscular weakness—Carmustine—malignant glioma	0.00309	0.00554	CcSEcCtD
Clonazepam—Breast disorder—Temozolomide—malignant glioma	0.00306	0.00549	CcSEcCtD
Clonazepam—GABRA1—cerebellum—malignant glioma	0.00306	0.0121	CbGeAlD
Clonazepam—CYP2E1—telencephalon—malignant glioma	0.00304	0.0121	CbGeAlD
Clonazepam—Dysphagia—Carmustine—malignant glioma	0.00303	0.00543	CcSEcCtD
Clonazepam—TSPO—central nervous system—malignant glioma	0.003	0.0119	CbGeAlD
Clonazepam—Muscular weakness—Temozolomide—malignant glioma	0.00299	0.00536	CcSEcCtD
Clonazepam—TSPO—cerebellum—malignant glioma	0.00293	0.0116	CbGeAlD
Clonazepam—Dysphagia—Temozolomide—malignant glioma	0.00293	0.00525	CcSEcCtD
Clonazepam—Bronchitis—Temozolomide—malignant glioma	0.00281	0.00505	CcSEcCtD
Clonazepam—GABRB2—brain—malignant glioma	0.00281	0.0112	CbGeAlD
Clonazepam—GABRG2—brain—malignant glioma	0.00281	0.0112	CbGeAlD
Clonazepam—Dysuria—Temozolomide—malignant glioma	0.00274	0.00491	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00272	0.00488	CcSEcCtD
Clonazepam—Pneumonia—Carmustine—malignant glioma	0.00271	0.00487	CcSEcCtD
Clonazepam—Pollakiuria—Temozolomide—malignant glioma	0.0027	0.00485	CcSEcCtD
Clonazepam—Erectile dysfunction—Temozolomide—malignant glioma	0.00269	0.00484	CcSEcCtD
Clonazepam—Depression—Carmustine—malignant glioma	0.00269	0.00483	CcSEcCtD
Clonazepam—Weight increased—Temozolomide—malignant glioma	0.00266	0.00478	CcSEcCtD
Clonazepam—Weight decreased—Temozolomide—malignant glioma	0.00265	0.00475	CcSEcCtD
Clonazepam—Neuropathy peripheral—Carmustine—malignant glioma	0.00265	0.00475	CcSEcCtD
Clonazepam—Urinary tract infection—Carmustine—malignant glioma	0.00262	0.00471	CcSEcCtD
Clonazepam—Pneumonia—Temozolomide—malignant glioma	0.00262	0.00471	CcSEcCtD
Clonazepam—Depression—Temozolomide—malignant glioma	0.0026	0.00467	CcSEcCtD
Clonazepam—Neuropathy peripheral—Temozolomide—malignant glioma	0.00256	0.00459	CcSEcCtD
Clonazepam—Urinary tract infection—Temozolomide—malignant glioma	0.00254	0.00455	CcSEcCtD
Clonazepam—GABRA1—brain—malignant glioma	0.00248	0.00986	CbGeAlD
Clonazepam—Sinusitis—Temozolomide—malignant glioma	0.00245	0.00439	CcSEcCtD
Clonazepam—Haemoglobin—Carmustine—malignant glioma	0.00244	0.00437	CcSEcCtD
Clonazepam—Haemorrhage—Carmustine—malignant glioma	0.00242	0.00435	CcSEcCtD
Clonazepam—Hypoaesthesia—Carmustine—malignant glioma	0.00241	0.00433	CcSEcCtD
Clonazepam—Hallucination—Carmustine—malignant glioma	0.00241	0.00433	CcSEcCtD
Clonazepam—CYP2E1—medulla oblongata—malignant glioma	0.00239	0.0095	CbGeAlD
Clonazepam—Oedema peripheral—Carmustine—malignant glioma	0.00239	0.00428	CcSEcCtD
Clonazepam—Connective tissue disorder—Carmustine—malignant glioma	0.00238	0.00427	CcSEcCtD
Clonazepam—TSPO—brain—malignant glioma	0.00238	0.00945	CbGeAlD
Clonazepam—Haemoglobin—Temozolomide—malignant glioma	0.00235	0.00422	CcSEcCtD
Clonazepam—Haemorrhage—Temozolomide—malignant glioma	0.00234	0.0042	CcSEcCtD
Clonazepam—Visual impairment—Carmustine—malignant glioma	0.00233	0.00419	CcSEcCtD
Clonazepam—Hypoaesthesia—Temozolomide—malignant glioma	0.00233	0.00418	CcSEcCtD
Clonazepam—Hallucination—Temozolomide—malignant glioma	0.00233	0.00418	CcSEcCtD
Clonazepam—Pharyngitis—Temozolomide—malignant glioma	0.00232	0.00417	CcSEcCtD
Clonazepam—ALB—brain—malignant glioma	0.00232	0.00922	CbGeAlD
Clonazepam—Urinary tract disorder—Temozolomide—malignant glioma	0.00231	0.00415	CcSEcCtD
Clonazepam—Oedema peripheral—Temozolomide—malignant glioma	0.00231	0.00414	CcSEcCtD
Clonazepam—Connective tissue disorder—Temozolomide—malignant glioma	0.0023	0.00413	CcSEcCtD
Clonazepam—Urethral disorder—Temozolomide—malignant glioma	0.0023	0.00412	CcSEcCtD
Clonazepam—Eye disorder—Carmustine—malignant glioma	0.00226	0.00406	CcSEcCtD
Clonazepam—Visual impairment—Temozolomide—malignant glioma	0.00226	0.00405	CcSEcCtD
Clonazepam—Flushing—Carmustine—malignant glioma	0.00225	0.00404	CcSEcCtD
Clonazepam—Eye disorder—Temozolomide—malignant glioma	0.00219	0.00393	CcSEcCtD
Clonazepam—Flushing—Temozolomide—malignant glioma	0.00217	0.0039	CcSEcCtD
Clonazepam—Cardiac disorder—Temozolomide—malignant glioma	0.00217	0.0039	CcSEcCtD
Clonazepam—Alopecia—Carmustine—malignant glioma	0.00214	0.00384	CcSEcCtD
Clonazepam—CYP2E1—spinal cord—malignant glioma	0.00213	0.00847	CbGeAlD
Clonazepam—Clotiazepam—CYP2C18—malignant glioma	0.00212	0.0799	CrCbGaD
Clonazepam—Mental disorder—Carmustine—malignant glioma	0.00212	0.00381	CcSEcCtD
Clonazepam—Immune system disorder—Temozolomide—malignant glioma	0.00211	0.0038	CcSEcCtD
Clonazepam—Malnutrition—Carmustine—malignant glioma	0.00211	0.00379	CcSEcCtD
Clonazepam—Chills—Temozolomide—malignant glioma	0.0021	0.00377	CcSEcCtD
Clonazepam—Alopecia—Temozolomide—malignant glioma	0.00207	0.00371	CcSEcCtD
Clonazepam—Mental disorder—Temozolomide—malignant glioma	0.00205	0.00368	CcSEcCtD
Clonazepam—Back pain—Carmustine—malignant glioma	0.00204	0.00366	CcSEcCtD
Clonazepam—Malnutrition—Temozolomide—malignant glioma	0.00204	0.00366	CcSEcCtD
Clonazepam—Vision blurred—Carmustine—malignant glioma	0.00199	0.00357	CcSEcCtD
Clonazepam—Tremor—Carmustine—malignant glioma	0.00198	0.00355	CcSEcCtD
Clonazepam—Back pain—Temozolomide—malignant glioma	0.00197	0.00354	CcSEcCtD
Clonazepam—Anaemia—Carmustine—malignant glioma	0.00195	0.0035	CcSEcCtD
Clonazepam—Agitation—Carmustine—malignant glioma	0.00194	0.00348	CcSEcCtD
Clonazepam—Vision blurred—Temozolomide—malignant glioma	0.00192	0.00345	CcSEcCtD
Clonazepam—Tremor—Temozolomide—malignant glioma	0.00191	0.00343	CcSEcCtD
Clonazepam—Ill-defined disorder—Temozolomide—malignant glioma	0.00189	0.00339	CcSEcCtD
Clonazepam—Leukopenia—Carmustine—malignant glioma	0.00189	0.00339	CcSEcCtD
Clonazepam—Anaemia—Temozolomide—malignant glioma	0.00188	0.00338	CcSEcCtD
Clonazepam—Agitation—Temozolomide—malignant glioma	0.00187	0.00336	CcSEcCtD
Clonazepam—Angioedema—Temozolomide—malignant glioma	0.00186	0.00334	CcSEcCtD
Clonazepam—Malaise—Temozolomide—malignant glioma	0.00184	0.0033	CcSEcCtD
Clonazepam—Vertigo—Temozolomide—malignant glioma	0.00183	0.00329	CcSEcCtD
Clonazepam—Leukopenia—Temozolomide—malignant glioma	0.00182	0.00327	CcSEcCtD
Clonazepam—Palpitations—Temozolomide—malignant glioma	0.0018	0.00323	CcSEcCtD
Clonazepam—Myalgia—Carmustine—malignant glioma	0.0018	0.00322	CcSEcCtD
Clonazepam—Chest pain—Carmustine—malignant glioma	0.0018	0.00322	CcSEcCtD
Clonazepam—Anxiety—Carmustine—malignant glioma	0.00179	0.00321	CcSEcCtD
Clonazepam—Cough—Temozolomide—malignant glioma	0.00178	0.00319	CcSEcCtD
Clonazepam—Confusional state—Carmustine—malignant glioma	0.00174	0.00311	CcSEcCtD
Clonazepam—Myalgia—Temozolomide—malignant glioma	0.00174	0.00311	CcSEcCtD
Clonazepam—Arthralgia—Temozolomide—malignant glioma	0.00174	0.00311	CcSEcCtD
Clonazepam—CYP2E1—central nervous system—malignant glioma	0.00173	0.00687	CbGeAlD
Clonazepam—Anxiety—Temozolomide—malignant glioma	0.00173	0.0031	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00172	0.00309	CcSEcCtD
Clonazepam—Oedema—Carmustine—malignant glioma	0.00172	0.00309	CcSEcCtD
Clonazepam—Discomfort—Temozolomide—malignant glioma	0.00171	0.00308	CcSEcCtD
Clonazepam—Infection—Carmustine—malignant glioma	0.00171	0.00307	CcSEcCtD
Clonazepam—Dry mouth—Temozolomide—malignant glioma	0.0017	0.00305	CcSEcCtD
Clonazepam—CYP2E1—cerebellum—malignant glioma	0.00169	0.00672	CbGeAlD
Clonazepam—Thrombocytopenia—Carmustine—malignant glioma	0.00169	0.00302	CcSEcCtD
Clonazepam—Tachycardia—Carmustine—malignant glioma	0.00168	0.00302	CcSEcCtD
Clonazepam—Confusional state—Temozolomide—malignant glioma	0.00168	0.00301	CcSEcCtD
Clonazepam—Oedema—Temozolomide—malignant glioma	0.00166	0.00299	CcSEcCtD
Clonazepam—Anaphylactic shock—Temozolomide—malignant glioma	0.00166	0.00299	CcSEcCtD
Clonazepam—Infection—Temozolomide—malignant glioma	0.00165	0.00297	CcSEcCtD
Clonazepam—Anorexia—Carmustine—malignant glioma	0.00164	0.00294	CcSEcCtD
Clonazepam—Nervous system disorder—Temozolomide—malignant glioma	0.00163	0.00293	CcSEcCtD
Clonazepam—Thrombocytopenia—Temozolomide—malignant glioma	0.00163	0.00292	CcSEcCtD
Clonazepam—Skin disorder—Temozolomide—malignant glioma	0.00162	0.0029	CcSEcCtD
Clonazepam—Hypotension—Carmustine—malignant glioma	0.00161	0.00289	CcSEcCtD
Clonazepam—Anorexia—Temozolomide—malignant glioma	0.00159	0.00285	CcSEcCtD
Clonazepam—Clotiazepam—CYP2B6—malignant glioma	0.00158	0.0593	CrCbGaD
Clonazepam—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00157	0.00281	CcSEcCtD
Clonazepam—Insomnia—Carmustine—malignant glioma	0.00156	0.00279	CcSEcCtD
Clonazepam—Dyspnoea—Carmustine—malignant glioma	0.00153	0.00275	CcSEcCtD
Clonazepam—Somnolence—Carmustine—malignant glioma	0.00153	0.00275	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00152	0.00272	CcSEcCtD
Clonazepam—Insomnia—Temozolomide—malignant glioma	0.0015	0.0027	CcSEcCtD
Clonazepam—Decreased appetite—Carmustine—malignant glioma	0.0015	0.00269	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Carmustine—malignant glioma	0.00149	0.00267	CcSEcCtD
Clonazepam—Dyspnoea—Temozolomide—malignant glioma	0.00148	0.00266	CcSEcCtD
Clonazepam—Somnolence—Temozolomide—malignant glioma	0.00148	0.00265	CcSEcCtD
Clonazepam—Constipation—Carmustine—malignant glioma	0.00147	0.00264	CcSEcCtD
Clonazepam—Pain—Carmustine—malignant glioma	0.00147	0.00264	CcSEcCtD
Clonazepam—Dyspepsia—Temozolomide—malignant glioma	0.00146	0.00263	CcSEcCtD
Clonazepam—Decreased appetite—Temozolomide—malignant glioma	0.00145	0.0026	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00144	0.00258	CcSEcCtD
Clonazepam—Fatigue—Temozolomide—malignant glioma	0.00143	0.00257	CcSEcCtD
Clonazepam—Pain—Temozolomide—malignant glioma	0.00142	0.00255	CcSEcCtD
Clonazepam—Constipation—Temozolomide—malignant glioma	0.00142	0.00255	CcSEcCtD
Clonazepam—Feeling abnormal—Carmustine—malignant glioma	0.00142	0.00255	CcSEcCtD
Clonazepam—Gastrointestinal pain—Carmustine—malignant glioma	0.00141	0.00253	CcSEcCtD
Clonazepam—CYP3A4—central nervous system—malignant glioma	0.00139	0.00553	CbGeAlD
Clonazepam—CYP2E1—brain—malignant glioma	0.00137	0.00546	CbGeAlD
Clonazepam—Feeling abnormal—Temozolomide—malignant glioma	0.00137	0.00246	CcSEcCtD
Clonazepam—Flunitrazepam—CYP2B6—malignant glioma	0.00136	0.0512	CrCbGaD
Clonazepam—Abdominal pain—Carmustine—malignant glioma	0.00136	0.00244	CcSEcCtD
Clonazepam—Body temperature increased—Carmustine—malignant glioma	0.00136	0.00244	CcSEcCtD
Clonazepam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00136	0.00244	CcSEcCtD
Clonazepam—Urticaria—Temozolomide—malignant glioma	0.00132	0.00237	CcSEcCtD
Clonazepam—Abdominal pain—Temozolomide—malignant glioma	0.00131	0.00236	CcSEcCtD
Clonazepam—Body temperature increased—Temozolomide—malignant glioma	0.00131	0.00236	CcSEcCtD
Clonazepam—Hypersensitivity—Carmustine—malignant glioma	0.00127	0.00228	CcSEcCtD
Clonazepam—Asthenia—Carmustine—malignant glioma	0.00124	0.00222	CcSEcCtD
Clonazepam—Hypersensitivity—Temozolomide—malignant glioma	0.00123	0.0022	CcSEcCtD
Clonazepam—Asthenia—Temozolomide—malignant glioma	0.00119	0.00214	CcSEcCtD
Clonazepam—Diarrhoea—Carmustine—malignant glioma	0.00118	0.00211	CcSEcCtD
Clonazepam—Pruritus—Temozolomide—malignant glioma	0.00118	0.00211	CcSEcCtD
Clonazepam—Diazepam—CYP2C18—malignant glioma	0.00117	0.044	CrCbGaD
Clonazepam—Dizziness—Carmustine—malignant glioma	0.00114	0.00204	CcSEcCtD
Clonazepam—Diarrhoea—Temozolomide—malignant glioma	0.00114	0.00204	CcSEcCtD
Clonazepam—Dizziness—Temozolomide—malignant glioma	0.0011	0.00197	CcSEcCtD
Clonazepam—Vomiting—Carmustine—malignant glioma	0.00109	0.00196	CcSEcCtD
Clonazepam—Rash—Carmustine—malignant glioma	0.00109	0.00195	CcSEcCtD
Clonazepam—Dermatitis—Carmustine—malignant glioma	0.00108	0.00195	CcSEcCtD
Clonazepam—Headache—Carmustine—malignant glioma	0.00108	0.00194	CcSEcCtD
Clonazepam—Vomiting—Temozolomide—malignant glioma	0.00106	0.0019	CcSEcCtD
Clonazepam—Rash—Temozolomide—malignant glioma	0.00105	0.00188	CcSEcCtD
Clonazepam—Dermatitis—Temozolomide—malignant glioma	0.00105	0.00188	CcSEcCtD
Clonazepam—Headache—Temozolomide—malignant glioma	0.00104	0.00187	CcSEcCtD
Clonazepam—Nausea—Carmustine—malignant glioma	0.00102	0.00183	CcSEcCtD
Clonazepam—Midazolam—CYP2B6—malignant glioma	0.00101	0.0381	CrCbGaD
Clonazepam—Nausea—Temozolomide—malignant glioma	0.000988	0.00177	CcSEcCtD
Clonazepam—Diazepam—CYP2B6—malignant glioma	0.000869	0.0327	CrCbGaD
Clonazepam—Diazepam—PTGS1—malignant glioma	0.000572	0.0215	CrCbGaD
Clonazepam—ALB—Platelet degranulation—PDGFB—malignant glioma	0.000242	0.00203	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IFNG—malignant glioma	0.000238	0.00199	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000233	0.00195	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.000231	0.00193	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00023	0.00192	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000229	0.00192	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000228	0.00191	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTT1—malignant glioma	0.000225	0.00188	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00022	0.00184	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00022	0.00184	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000219	0.00183	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—FN1—malignant glioma	0.000219	0.00183	CbGpPWpGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000216	0.00181	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL1B—malignant glioma	0.000212	0.00177	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS1—malignant glioma	0.000211	0.00176	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000211	0.00176	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00021	0.00175	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.000208	0.00174	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—EGF—malignant glioma	0.000207	0.00173	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000207	0.00173	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000206	0.00172	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—RAF1—malignant glioma	0.000204	0.00171	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—F2—malignant glioma	0.000203	0.00169	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.000197	0.00165	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000197	0.00165	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—BCHE—malignant glioma	0.000196	0.00164	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—RTEL1—malignant glioma	0.000196	0.00164	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—RAF1—malignant glioma	0.000195	0.00163	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SLC5A5—malignant glioma	0.000194	0.00162	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—malignant glioma	0.000193	0.00162	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IFNG—malignant glioma	0.000193	0.00162	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—malignant glioma	0.000191	0.0016	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ATP1B2—malignant glioma	0.00019	0.00159	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000189	0.00158	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000189	0.00158	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—RAF1—malignant glioma	0.000187	0.00156	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000185	0.00154	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000184	0.00154	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000183	0.00153	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000182	0.00152	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000179	0.0015	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000173	0.00145	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000172	0.00144	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL1B—malignant glioma	0.000172	0.00144	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL2—malignant glioma	0.000172	0.00144	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000171	0.00143	CbGpPWpGaD
Clonazepam—ALB—Metabolism—RTEL1—malignant glioma	0.000168	0.00141	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000165	0.00138	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000165	0.00138	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000165	0.00138	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000165	0.00138	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000165	0.00138	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000164	0.00137	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000163	0.00136	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	0.00016	0.00134	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.00016	0.00134	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000158	0.00132	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—BRAF—malignant glioma	0.000158	0.00132	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000158	0.00132	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000158	0.00132	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000158	0.00132	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000157	0.00131	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000157	0.00131	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTP1—malignant glioma	0.000156	0.0013	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	0.000154	0.00129	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	0.000154	0.00128	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CAT—malignant glioma	0.000152	0.00127	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000151	0.00127	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000151	0.00126	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—BRAF—malignant glioma	0.000151	0.00126	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000151	0.00126	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.00015	0.00125	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00015	0.00125	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000148	0.00124	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000147	0.00123	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—BRAF—malignant glioma	0.000145	0.00121	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NCOR1—malignant glioma	0.000143	0.0012	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000143	0.0012	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000143	0.0012	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000141	0.00118	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ANGPT2—malignant glioma	0.00014	0.00117	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000139	0.00117	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000139	0.00116	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000138	0.00116	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000138	0.00115	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.000137	0.00115	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—MDM2—malignant glioma	0.000133	0.00111	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—RAF1—malignant glioma	0.000132	0.0011	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000132	0.0011	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.00013	0.00108	CbGpPWpGaD
Clonazepam—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000129	0.00108	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000128	0.00107	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000128	0.00107	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—BRAF—malignant glioma	0.000127	0.00106	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—MDM2—malignant glioma	0.000127	0.00106	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—RAF1—malignant glioma	0.000126	0.00105	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000125	0.00105	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—VEGFA—malignant glioma	0.000125	0.00105	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TNF—malignant glioma	0.000125	0.00105	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000122	0.00102	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000121	0.00101	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—MDM2—malignant glioma	0.000121	0.00101	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—RAF1—malignant glioma	0.000121	0.00101	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MYB—malignant glioma	0.00012	0.00101	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00012	0.001	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000119	0.000997	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CAV1—malignant glioma	0.000117	0.000978	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000116	0.000972	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—COX8A—malignant glioma	0.000112	0.000939	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—malignant glioma	0.00011	0.000922	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00011	0.000918	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000108	0.000899	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CG—malignant glioma	0.000107	0.00089	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—MDM2—malignant glioma	0.000106	0.000886	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—RAF1—malignant glioma	0.000106	0.000883	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PPARG—malignant glioma	0.000103	0.000859	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—malignant glioma	9.94e-05	0.000831	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	9.7e-05	0.000811	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	9.7e-05	0.000811	CbGpPWpGaD
Clonazepam—ALB—Metabolism—COX8A—malignant glioma	9.66e-05	0.000807	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ASMT—malignant glioma	9.55e-05	0.000799	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—H3F3A—malignant glioma	9.39e-05	0.000785	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CD—malignant glioma	9.36e-05	0.000783	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	9.28e-05	0.000776	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	9.18e-05	0.000767	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—RTEL1—malignant glioma	9.08e-05	0.000759	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—BCAN—malignant glioma	8.98e-05	0.000751	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	8.98e-05	0.00075	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	8.85e-05	0.00074	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.63e-05	0.000722	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	8.5e-05	0.00071	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ASMT—malignant glioma	8.21e-05	0.000686	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	8.21e-05	0.000686	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	8.16e-05	0.000682	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CB—malignant glioma	8.16e-05	0.000682	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—malignant glioma	8.09e-05	0.000676	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.03e-05	0.000671	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KNG1—malignant glioma	7.74e-05	0.000647	CbGpPWpGaD
Clonazepam—ALB—Metabolism—BCAN—malignant glioma	7.72e-05	0.000645	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNA2—malignant glioma	7.58e-05	0.000634	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.54e-05	0.00063	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	7.29e-05	0.000609	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—IDH2—malignant glioma	7.24e-05	0.000605	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SOD1—malignant glioma	7.19e-05	0.000601	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.17e-05	0.0006	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	7.11e-05	0.000595	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.11e-05	0.000594	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTEN—malignant glioma	7.05e-05	0.00059	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP2B6—malignant glioma	6.81e-05	0.000569	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	6.78e-05	0.000567	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PTK2—malignant glioma	6.6e-05	0.000552	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	6.53e-05	0.000546	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	6.5e-05	0.000543	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—IDH1—malignant glioma	6.23e-05	0.000521	CbGpPWpGaD
Clonazepam—ALB—Metabolism—IDH2—malignant glioma	6.22e-05	0.00052	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SPHK1—malignant glioma	6.02e-05	0.000504	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP2C18—malignant glioma	5.9e-05	0.000493	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.87e-05	0.000491	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP2B6—malignant glioma	5.85e-05	0.000489	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.68e-05	0.000475	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	5.55e-05	0.000464	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PDGFB—malignant glioma	5.54e-05	0.000464	CbGpPWpGaD
Clonazepam—ALB—Metabolism—IDH1—malignant glioma	5.35e-05	0.000447	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CAV1—malignant glioma	5.25e-05	0.000439	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—COX8A—malignant glioma	5.21e-05	0.000436	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SPHK1—malignant glioma	5.18e-05	0.000433	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP2C18—malignant glioma	5.07e-05	0.000424	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—F2—malignant glioma	5e-05	0.000418	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—FN1—malignant glioma	5e-05	0.000418	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CA—malignant glioma	4.98e-05	0.000416	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CG—malignant glioma	4.79e-05	0.0004	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.78e-05	0.0004	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTT1—malignant glioma	4.77e-05	0.000399	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—EGF—malignant glioma	4.73e-05	0.000395	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PTPN11—malignant glioma	4.7e-05	0.000393	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS1—malignant glioma	4.47e-05	0.000374	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ASMT—malignant glioma	4.43e-05	0.000371	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—AKT2—malignant glioma	4.38e-05	0.000366	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.36e-05	0.000364	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	4.34e-05	0.000363	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CD—malignant glioma	4.21e-05	0.000352	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.21e-05	0.000352	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—BCAN—malignant glioma	4.17e-05	0.000348	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—BCHE—malignant glioma	4.16e-05	0.000348	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC5A5—malignant glioma	4.11e-05	0.000343	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTT1—malignant glioma	4.1e-05	0.000343	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—AKT1—malignant glioma	4.06e-05	0.00034	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS1—malignant glioma	3.84e-05	0.000321	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.83e-05	0.00032	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAF1—malignant glioma	3.76e-05	0.000314	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CB—malignant glioma	3.67e-05	0.000307	CbGpPWpGaD
Clonazepam—ALB—Metabolism—BCHE—malignant glioma	3.57e-05	0.000299	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	3.54e-05	0.000296	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC5A5—malignant glioma	3.53e-05	0.000295	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IL2—malignant glioma	3.37e-05	0.000282	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—IDH2—malignant glioma	3.36e-05	0.000281	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.34e-05	0.000279	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—malignant glioma	3.31e-05	0.000277	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.31e-05	0.000277	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	3.25e-05	0.000272	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CAT—malignant glioma	3.22e-05	0.000269	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.16e-05	0.000264	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NCOR1—malignant glioma	3.04e-05	0.000254	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—IDH1—malignant glioma	2.89e-05	0.000241	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.88e-05	0.000241	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFA—malignant glioma	2.86e-05	0.000239	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—malignant glioma	2.84e-05	0.000238	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SPHK1—malignant glioma	2.8e-05	0.000234	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CAT—malignant glioma	2.77e-05	0.000231	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.74e-05	0.000229	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NCOR1—malignant glioma	2.61e-05	0.000218	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CAV1—malignant glioma	2.48e-05	0.000207	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KRAS—malignant glioma	2.43e-05	0.000203	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CG—malignant glioma	2.26e-05	0.000189	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CA—malignant glioma	2.24e-05	0.000187	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTT1—malignant glioma	2.21e-05	0.000185	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PPARG—malignant glioma	2.18e-05	0.000182	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—malignant glioma	2.16e-05	0.000181	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CAV1—malignant glioma	2.13e-05	0.000178	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS1—malignant glioma	2.08e-05	0.000173	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.04e-05	0.00017	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CD—malignant glioma	1.98e-05	0.000166	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CG—malignant glioma	1.94e-05	0.000162	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—BCHE—malignant glioma	1.93e-05	0.000161	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.91e-05	0.000159	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PPARG—malignant glioma	1.87e-05	0.000157	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—AKT1—malignant glioma	1.83e-05	0.000153	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.73e-05	0.000145	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—malignant glioma	1.71e-05	0.000143	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CD—malignant glioma	1.71e-05	0.000143	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—malignant glioma	1.54e-05	0.000128	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTEN—malignant glioma	1.49e-05	0.000125	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CAT—malignant glioma	1.49e-05	0.000125	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CB—malignant glioma	1.49e-05	0.000124	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—malignant glioma	1.47e-05	0.000123	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000118	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTEN—malignant glioma	1.28e-05	0.000107	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CAV1—malignant glioma	1.15e-05	9.61e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.05e-05	8.82e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.05e-05	8.76e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PPARG—malignant glioma	1.01e-05	8.45e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.21e-06	7.7e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CA—malignant glioma	9.06e-06	7.58e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—AKT1—malignant glioma	8.62e-06	7.2e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.03e-06	6.71e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—malignant glioma	7.95e-06	6.65e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—AKT1—malignant glioma	7.4e-06	6.19e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTEN—malignant glioma	6.94e-06	5.8e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.89e-06	4.09e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—AKT1—malignant glioma	4e-06	3.34e-05	CbGpPWpGaD
